TY - JOUR
T1 - Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31
T2 - Implication for the immunopathogenesis of atopic dermatitis
AU - Cheung, Phyllis Fung Yi
AU - Wong, Chun Kwok
AU - Ho, Amy Wing Yin
AU - Hu, Shuiqing
AU - Chen, Da Peng
AU - Lam, Christopher Wai Kei
PY - 2010/4/21
Y1 - 2010/4/21
N2 - IL-31 is a novel Th type 2 cytokine that can induce pruritus and dermatitis in mice resembling human atopic dermatitis (AD). Eosinophil infiltration in skin lesions is a predominant pathological feature of AD. In the present study, we investigated the effects of IL-31 on the activation of human eosinophils and epidermal keratinocytes. Eosinophils and keratinocytes were cultured either together or separately in the presence or absence of IL-31 stimulation. IL-31 could significantly induce the release of pro-inflammatory cytokines IL-1β, IL-6 and AD-related chemokines CXCL1, CXCL8, CCL2 and CCL18 from eosinophils, via functional cell surface IL-31 receptor. Such induction was further enhanced upon the co-culture of eosinophils and keratinocytes, in which eosinophils were the main source for releasing pro-inflammatory cytokines and chemokines. The presence of transwell inserts in co-culture system demonstrated that the direct interaction between eosinophils and keratinocytes was required for IL-31-induced cytokine and chemokine release. Cell surface expression of adhesion molecule CD18 on eosinophils and intercellular adhesion molecule-1 on keratinocytes was up-regulated in the co-culture, and levels were further enhanced upon IL-31 stimulation. The interaction between eosinophils and keratinocytes under IL-31 stimulation was differentially mediated through intracellular mitogen-activated protein kinases, nuclear factor-κB and phosphatidylinositol 3-kinase-Akt pathways. The above findings suggest a crucial immunopathological role of IL-31 in AD through activation of eosinophils-keratinocytes system.
AB - IL-31 is a novel Th type 2 cytokine that can induce pruritus and dermatitis in mice resembling human atopic dermatitis (AD). Eosinophil infiltration in skin lesions is a predominant pathological feature of AD. In the present study, we investigated the effects of IL-31 on the activation of human eosinophils and epidermal keratinocytes. Eosinophils and keratinocytes were cultured either together or separately in the presence or absence of IL-31 stimulation. IL-31 could significantly induce the release of pro-inflammatory cytokines IL-1β, IL-6 and AD-related chemokines CXCL1, CXCL8, CCL2 and CCL18 from eosinophils, via functional cell surface IL-31 receptor. Such induction was further enhanced upon the co-culture of eosinophils and keratinocytes, in which eosinophils were the main source for releasing pro-inflammatory cytokines and chemokines. The presence of transwell inserts in co-culture system demonstrated that the direct interaction between eosinophils and keratinocytes was required for IL-31-induced cytokine and chemokine release. Cell surface expression of adhesion molecule CD18 on eosinophils and intercellular adhesion molecule-1 on keratinocytes was up-regulated in the co-culture, and levels were further enhanced upon IL-31 stimulation. The interaction between eosinophils and keratinocytes under IL-31 stimulation was differentially mediated through intracellular mitogen-activated protein kinases, nuclear factor-κB and phosphatidylinositol 3-kinase-Akt pathways. The above findings suggest a crucial immunopathological role of IL-31 in AD through activation of eosinophils-keratinocytes system.
KW - Adhesion molecules
KW - Chemokines
KW - Eosinophils
KW - IL-31
KW - Keratinocytes
KW - Mitogen-activated protein kinases
KW - Signaling molecules
UR - http://www.scopus.com/inward/record.url?scp=77953963592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953963592&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxq027
DO - 10.1093/intimm/dxq027
M3 - Article
C2 - 20410259
AN - SCOPUS:77953963592
SN - 0953-8178
VL - 22
SP - 453
EP - 467
JO - International Immunology
JF - International Immunology
IS - 6
ER -